Read About HIV Genome Integration and Viral Persistence

How HIV Genome Integration Occurs

HIV genome integration takes place after the virus enters a CD4 T lymphocyte and converts its RNA into DNA. The viral enzyme integrase then helps insert this DNA into the host cell’s genetic material. Integration enables HIV to establish a lasting presence within an infected cell. The process forms part of the HIV life cycle and is essential for productive infection.

Several stages contribute to HIV genome integration:

• Reverse transcription: HIV reverse transcriptase converts viral RNA into DNA.
• Nuclear entry: The viral DNA enters the nucleus of the host cell.
• Integration: The integrase enzyme inserts viral DNA into the host genome.
• Provirus formation: The integrated viral DNA becomes a provirus within the cell’s genetic material.
• Viral gene expression: When the provirus is active, the host cell’s machinery can produce viral RNA and proteins.

Integration does not always result in immediate viral production. The activity of the integrated provirus depends on cellular conditions, regulatory mechanisms, and the surrounding genomic environment. Some integrated viral DNA may contain defects that prevent the production of infectious virus, while other proviruses can remain capable of replication.

HIV Viral Persistence and Latent Reservoirs

HIV viral persistence refers to the continued presence of HIV or HIV-infected cells in the body, including during effective antiretroviral therapy. One important mechanism involves latent HIV reservoirs, which contain infected cells that are not actively producing new viral particles. Resting memory CD4 T cells are a well-established reservoir for latent, replication-competent HIV.

Important aspects of viral persistence include:

• Latent infection: Some infected cells contain integrated HIV DNA but produce little or no viral material.
• Long-lived infected cells: Certain infected cells can survive for extended periods, helping maintain persistent HIV infection.
• Clonal expansion: Some infected cells divide and produce genetically related cells that carry the same integrated provirus.
• Viral rebound: If antiretroviral treatment is interrupted, HIV from persistent reservoirs can contribute to renewed viral replication.
• Treatment limitations: Antiretroviral therapy suppresses HIV replication but does not generally eliminate all latent infected cells.

The location of HIV integration within the host genome may influence how a provirus behaves. Research has identified integration preferences and associations with cellular gene activity. In some cases, integration and the expansion of infected cell populations may contribute to long-term persistence. However, the precise contribution of individual integration sites and cellular mechanisms remains an area of investigation.

HIV genome integration and viral persistence are closely connected biological processes that help explain why HIV treatment requires ongoing management. Antiretroviral therapy can reduce viral load and protect immune function, while research continues to investigate methods for targeting latent reservoirs and achieving sustained HIV remission.